Group One Trading’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$27.5K 8904
2025
Q4
$27.5K Sell
100
-500
-83% -$137K ﹤0.01% 6097
2025
Q3
$157K Buy
600
+200
+50% +$48.6K ﹤0.01% 4929
2025
Q2
$87.5K Sell
400
-10,300
-96% -$2.2M ﹤0.01% 5093
2025
Q1
$2.4M Buy
10,700
+1,700
+19% +$469K 0.01% 1664
2024
Q4
$2.95M Sell
9,000
-4,700
-34% -$1.48M 0.01% 1585
2024
Q3
$4.11M Hold
13,700
0.01% 1150
2024
Q2
$4.51M Sell
13,700
-2,300
-14% -$813K 0.02% 872
2024
Q1
$6.33M Hold
16,000
0.02% 681
2023
Q4
$5.63M Buy
+16,000
New +$5.66M 0.01% 1042
2022
Q3
Sell
-28,100
Closed -$8.5M 8344
2022
Q2
$8.5M Hold
28,100
0.01% 956
2022
Q1
$11.5M Buy
+28,100
New +$11M 0.01% 897
2021
Q3
Sell
-600
Closed -$215K 8878
2021
Q2
$215K Buy
600
+400
+200% +$132K ﹤0.01% 5172
2021
Q1
$56K Buy
+200
New +$57.2K ﹤0.01% 6142
2019
Q4
Sell
-1,700
Closed -$241K 5687
2019
Q3
$241K Hold
1,700
﹤0.01% 2948
2019
Q2
$213K Buy
+1,700
New +$201K ﹤0.01% 2806

Other funds holding WST

Group One Trading's WST Position: Q1 2026 in Review

Group One Trading sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 393 shares — an estimated $108K sold.

Group One Trading first reported a position in WST in Q2 2019 and held it in 12 quarters. The position peaked at $6.2M in Q2 2022. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Group One Trading reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 393 West Pharmaceutical shares in Q1 2026, an estimated $108K.
  • Group One Trading first reported a position in West Pharmaceutical in Q2 2019 and held it in 12 quarters.
  • Group One Trading's West Pharmaceutical position peaked at $6.2M in Q2 2022.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.